Albert Jang

25PUBLICATIONS
95CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyVeterinary anaesthesiology and intensive careCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma.

|Feb 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer.

Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos

|Dec 13, 2025
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025.

Albert Jang, Yousef Zakharia, Pedro C Barata

|Nov 26, 2025
Superwarfarin Rodenticide Poisoning due to Consumption of Exotic Animals: A Case Report.

Batoul Sadek, Cassandra Dasmarinas, Ishita Patel

|Oct 21, 2025
Management of Renal Cell Carcinoma of Variant Histology.

Luciana Chagas Prado, Albert Jang, Milena S Tariki

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

Pageof 5

Frequent Collaborators

13 joint publications

Pedro C Barata

6 joint publications

Jason R Brown

3 joint publications

Yousef Zakharia

2 joint publications

Li Jiao